September 19, 2022 Prenatal and postpartum care for those who engage in substance use during pregnancy is more likely to be delayed or inadequate in states with policies that consider prenatal substance use to be child abuse or that require health care providers to report prenatal substance use to child welfare agencies.
September 15, 2022 During the Fall 2020 semester, UNC explored hybrid options to minimize COVID-19 transmission while still offering an on-campus experience for students. New research from the Gillings School sheds light on how this experience impacted COVID-19 cases among undergraduates.
August 25, 2022
Recent doctoral alumna Victoria Shelus conducted her dissertation research in Bugoye, Uganda, to understand the role that local drug shops play in making antimalarial treatments more accessible and how they can be leveraged to manage the spread of malaria in the region.
August 18, 2022 "Our message is that people should take as many steps as possible throughout the day at any walk pace, trying to work in a brisk walk for part of the day to gain the greatest benefit in lowering their risk of diabetes."
August 15, 2022 Hincapie-Castillo assesses COVID-19 dashboards in public schools, Rothenberg is named RTI International's Mentee of the Year and students from biostatistics are honored for research.
August 12, 2022 Gillings faculty have recently completed four GILs, including two from Round 6 of GIL funding and two from the special COVID-19 round of funding. The results of their work have furthered our understanding of energy storage, brain health, environmental exposures, viral transmission, pandemic response and more.
July 25, 2022 Gillings researchers are recognized for work in pharmacoepidemiology, public health leadership and marine environmental sciences, and a recent alumnus receives outstanding dissertation honors.
July 15, 2022 A clinical trial led by the NIH, with support from the Duke Clinical Research Institute and the Gillings School, recently showed that using infliximab or abatacept to treat adults hospitalized with COVID-19 did not shorten recovery time but did improve survival rates.
June 29, 2022 Recently published in eBioMedicine, this study represents work that originated with the late Gillings School professor Dr. Steve Meshnick.
June 24, 2022 Removing the Medicaid requirement for prior approval to fill prescriptions for buprenorphine, a common treatment for opioid use disorder, could lead to more patients gaining access to this life-saving medication.
